Literature DB >> 7097320

Myotonia, a new inherited muscle disease in mice.

A H Heller, E M Eicher, M Hallett, R L Sidman.   

Abstract

Electromyographic (EMG) and histological studies were carried out with the new mouse mutant myotonia (mto, autosomal recessive). Affected animals exhibited behavioral myotonia which was apparent at 2 weeks of age. EMG studies revealed myotonic discharges (prolonged repetitive discharges with recurrent variation in amplitude and frequency) in all skeletal muscles tested. These discharges were not affected by peripheral nerve section or by pancuronium bromide, a neuromuscular synapse inhibitor. Qualitative histological study revealed no evidence of skeletal muscle fiber necrosis, grouped atrophy, or inflammation compared toi sex-, age-, and weight-matched controls. Degeneration of myelinated axons in the ventrolateral funiculus of the spinal cord occurred only in older animals and does not explain the functional abnormality of muscle. Both the clinical and electrophysiological features of classical myotonia can be inherited as a single locus autosomal recessive disease in mice.

Entities:  

Mesh:

Year:  1982        PMID: 7097320      PMCID: PMC6564391     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

1.  Skeletal muscle changes associated with equine myotonic dystrophy.

Authors:  G A Hegreberg; S M Reed
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Chloride conductance in mouse muscle is subject to post-transcriptional compensation of the functional Cl- channel 1 gene dosage.

Authors:  M F Chen; R Niggeweg; P A Iaizzo; F Lehmann-Horn; H Jockusch
Journal:  J Physiol       Date:  1997-10-01       Impact factor: 5.182

3.  Fatigue-inducing stimulation resolves myotonia in a drug-induced model.

Authors:  Erik van Lunteren; Sarah E Spiegler; Michelle Moyer
Journal:  BMC Physiol       Date:  2011-02-28

4.  Increased density of satellite cells in the absence of fibre degeneration in muscle of myotonic mice.

Authors:  J Schimmelpfeng; H Jockusch; P Heimann
Journal:  Cell Tissue Res       Date:  1987-08       Impact factor: 5.249

5.  Developmental control of the excitability of muscle: transplantation experiments on a myotonic mouse mutant.

Authors:  E M Füchtbauer; J Reininghaus; H Jockusch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function.

Authors:  Sabata Pierno; Domenico Tricarico; Antonella Liantonio; Antonietta Mele; Claudio Digennaro; Jean-François Rolland; Gianpatrizio Bianco; Luciano Villanova; Alessandro Merendino; Giulia Maria Camerino; Annamaria De Luca; Jean-François Desaphy; Diana Conte Camerino
Journal:  Age (Dordr)       Date:  2013-05-30

7.  Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.

Authors:  S Pierno; G M Camerino; V Cippone; J-F Rolland; J-F Desaphy; A De Luca; A Liantonio; G Bianco; J D Kunic; A L George; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

8.  Impaired Wheel Running Exercise in CLC-1 Chloride Channel-Deficient Myotonic Mice.

Authors:  Erik van Lunteren; Michelle Moyer; Jessica Cooperrider; Jennifer Pollarine
Journal:  Front Physiol       Date:  2011-08-09       Impact factor: 4.566

9.  In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.

Authors:  Jean-François Desaphy; Teresa Costanza; Roberta Carbonara; Diana Conte Camerino
Journal:  Neuropharmacology       Date:  2012-09-18       Impact factor: 5.250

10.  A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin β1 subunit, Lamb1.

Authors:  Yi Bessie Liu; Ambika Tewari; Johnny Salameh; Elena Arystarkhova; Thomas G Hampton; Allison Brashear; Laurie J Ozelius; Kamran Khodakhah; Kathleen J Sweadner
Journal:  Elife       Date:  2015-12-24       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.